首页> 外国专利> Oral Tablet Formulation Consisting of Immediate Release Rosuvastatin and Extended Release Metformin

Oral Tablet Formulation Consisting of Immediate Release Rosuvastatin and Extended Release Metformin

机译:速释瑞舒伐他汀和缓释二甲双胍组成的口服片剂

摘要

The present invention is directed to solid dosage product and formulation containing a fixed combination of rosuvastatin and metformin such that rosuvastatin is delivered immediately to the patient and metformin is delivered in a controlled fashion over a longer course of time, also described as extended release, as well as to methods of making such solid dosage forms and method of treating patients with fixed combination solid dosage forms of immediate release rosuvastatin and extended release metformin.
机译:本发明涉及包含罗苏伐他汀和二甲双胍的固定组合的固体剂型产品和制剂,使得罗苏伐他汀被立即递送给患者,并且二甲双胍以可控的方式在更长的时间内被递送,也被称为延长释放,如以及制备这种固体剂型的方法和用速释瑞舒伐他汀和缓释二甲双胍的固定组合固体剂型治疗患者的方法。

著录项

  • 公开/公告号US2020222401A1

    专利类型

  • 公开/公告日2020-07-16

    原文格式PDF

  • 申请/专利权人 ALTHERA LIFE SCIENCES LLC;

    申请/专利号US202016795650

  • 发明设计人 MARIE CHARMAINE DIAS;

    申请日2020-02-20

  • 分类号A61K31/505;A61K31/155;A61K9/20;A61K9/28;

  • 国家 US

  • 入库时间 2022-08-21 11:26:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号